Literature DB >> 8831774

Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.

Z Li1, A C Ortega-Vilain, G S Patil, D L Chu, J E Foreman, D D Eveleth, J C Powers.   

Abstract

A series of new dipeptidyl alpha-keto amides of the general structure R1-L-Leu-D,L-AA-CONH-R2 were synthesized and evaluated as inhibitors for the cysteine proteases calpain I, calpain II, and cathepsin B. They combine 10 different N-protecting groups (R1), 3 amino acids residues in P1 (AA), and 44 distinct substituents on the alpha-keto amide nitrogen (R2). In general, calpain II was more sensitive to these inhibitors than calpain I, with a large number of inhibitors displaying dissociation constants (Ki) in the 10-100 nM range. Calpain I was also effectively inhibited, but very low Ki values were observed with a smaller number of inhibitors than with calpain II. Cathepsin B was weakly inhibited by most compounds in this study. The best inhibitors for calpain II were Z-Leu-Abu-CONH-CH2-CHOH-C6H5 (Ki = 15 nM), Z-Leu-Abu-CONH-CH2-2-pyridyl (Ki = 17 nM), and Z-Leu-Abu-CONH-CH2-C6H3(3,5(OMe)2) (Ki = 22 nM). The best calpain I inhibitor in this study was Z-Leu-Nva-CONH-CH2-2-pyridyl (Ki = 19 nM). The peptide alpha-keto amide Z-Leu-Abu-CONH-(CH2)2-3-indolyl was the best inhibitor for cathepsin B (Ki = 31 nM). Some compounds acted as specific calpain inhibitors, with comparable activity on both calpains I and II and a lack of activity on cathepsin B (e.g., 40, 42, 48, 70). Others were specific inhibitors for calpain I (e.g., 73) or calpain II (e.g., 18, 19, 33, 35, 56). Such inhibitors may be useful in elucidating the physiological and pathological events involving these proteases and may become possible therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831774     DOI: 10.1021/jm950541c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

Review 1.  Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Authors:  Michel Baudry; Xiaoning Bi
Journal:  Trends Neurosci       Date:  2016-02-10       Impact factor: 13.837

2.  Synthetic routes and lipase-inhibiting activity of long-chain alpha-keto amides.

Authors:  A Chiou; R Verger; G Kokotos
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

Review 3.  Using specificity to strategically target proteases.

Authors:  Mark D Lim; Charles S Craik
Journal:  Bioorg Med Chem       Date:  2008-03-30       Impact factor: 3.641

4.  A calpain-2 selective inhibitor enhances learning & memory by prolonging ERK activation.

Authors:  Yan Liu; Yubin Wang; Guoqi Zhu; Jiandong Sun; Xiaoning Bi; Michel Baudry
Journal:  Neuropharmacology       Date:  2016-02-18       Impact factor: 5.250

Review 5.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

6.  Ranking Reversible Covalent Drugs: From Free Energy Perturbation to Fragment Docking.

Authors:  Han Zhang; Wenjuan Jiang; Payal Chatterjee; Yun Luo
Journal:  J Chem Inf Model       Date:  2019-02-27       Impact factor: 4.956

7.  Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Authors:  Yubin Wang; Victor Briz; Athar Chishti; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

8.  Calpain regulates neutrophil chemotaxis.

Authors:  M A Lokuta; P A Nuzzi; A Huttenlocher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-20       Impact factor: 11.205

9.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

Review 10.  Multiple cellular cascades participate in long-term potentiation and in hippocampus-dependent learning.

Authors:  Michel Baudry; Guoqi Zhu; Yan Liu; Yubin Wang; Victor Briz; Xiaoning Bi
Journal:  Brain Res       Date:  2014-12-04       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.